Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2025-07-07 00:00:00 ET · period of report 2025-07-07 · accession 0001415889-25-019433 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-07-07 | 2025-07-07 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $8.71 | -1,119 | 54.8K | -2% | -$9,746 |
| D | 2025-07-07 | 2025-07-07 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.35 | +2,127 | 55.9K | +4% | +$4,998 |
| D | 2025-07-07 | 2025-07-07 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.35 | -2,127 | 178.4K | -1% | -$4,998 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-07-07 | S | D | 1,119 | $8.71 | 54,792 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2025-07-07 | M | A | 2,127 | $2.35 | 55,911 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023. |
| 3 | Derivative | Common Shares | 2025-07-07 | M | D | 2,127 | $2.35 | 178,406 | D | $2.35 · 2015-08-03 to 2025-08-03 | 2,127 Options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023. |